Pharmaceutical Product Development (United States)

841 papers and 28.1k indexed citations i.

About

In recent decades, authors affiliated with Pharmaceutical Product Development (United States) have published 841 papers, which have received a total of 28.1k indexed citations. Scholars at this organization have produced 259 papers in Molecular Biology, 80 papers in Infectious Diseases and 79 papers in Immunology on the topics of Protein purification and stability (75 papers), Monoclonal and Polyclonal Antibodies Research (59 papers) and Genetic and Kidney Cyst Diseases (57 papers). Their work is cited by papers focused on Molecular Biology (10.4k citations), Genetics (3.2k citations) and Radiology, Nuclear Medicine and Imaging (3.1k citations). Authors at Pharmaceutical Product Development (United States) collaborate with scholars in United States, Japan and Germany and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Pharmaceutical Product Development (United States)'s most productive authors include Robert S. Wallis, Frank S. Czerwiec, Carole W. Cranor, Dale B. Christensen, Alla Danilkovitch‐Miagkova, Steven J. Shire, John Ouyang, Vicente E. Torres, Berton Zbar and Arlene B. Chapman.

In The Last Decade

Fields of papers published by authors at Pharmaceutical Product Development (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication.

Countries citing scholars working at Pharmaceutical Product Development (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Pharmaceutical Product Development (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pharmaceutical Product Development (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmaceutical Product Development (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Laboratoire des Systèmes Mécaniques et d'Ingénierie Simultanée Breakdown of academic impact, for scholars at Golisano Children's Hospital Breakdown of academic impact, for scholars at Fairchild Semiconductor (United States) Breakdown of academic impact, for scholars at Johns Hopkins University School of Advanced International Studies Breakdown of academic impact, for scholars at Hôpital Broca Breakdown of academic impact, for scholars at Mediterranean Agronomic Institute of Chania Breakdown of academic impact, for scholars at Norwegian Computing Center Breakdown of academic impact, for scholars at Hôpital Saint-François d'Assise